Similar articles

• Glucocorticoid receptor-activator protein-I interactions in drug design.

  Wade EJ, Heck S, Cato AC. Wade EJ, et al. Biochem Soc Trans. 1995 Nov;23(4):946-52. doi: 10.1042/bst0230946. Biochem Soc Trans. 1995. PMID: 8654872 No abstract available.
• Ursolic acid-induced down-regulation of MMP-9 gene is mediated through the nuclear translocation of glucocorticoid receptor in HT1080 human fibrosarcoma cells.

  Cha HJ, Park MT, Chung HY, Kim ND, Sato H, Seiki M, Kim KW. Cha HJ, et al. Oncogene. 1998 Feb 12;16(6):771-8. doi: 10.1038/sj.onc.1201587. Oncogene. 1998. PMID: 9488041
• Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia.

  Tissing WJ, Meijerink JP, den Boer ML, Pieters R. Tissing WJ, et al. Leukemia. 2003 Jan;17(1):17-25. doi: 10.1038/sj.leu.2402733. Leukemia. 2003. PMID: 12529655 Review.
• Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1.

  Biola A, Lefebvre P, Perrin-Wolff M, Sturm M, Bertoglio J, Pallardy M. Biola A, et al. Mol Endocrinol. 2001 Jul;15(7):1062-76. doi: 10.1210/mend.15.7.0657. Mol Endocrinol. 2001. PMID: 11435608
• [Mode of action of glucocorticoids].

  Biola A, Pallardy M. Biola A, et al. Presse Med. 2000 Feb 5;29(4):215-23. Presse Med. 2000. PMID: 10705903 Review. French.